E
REGENXBIO Inc. RGNX
$6.72 $0.172.60%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue -4.50% -16.31% 11.60% -18.37% -29.13%
Total Other Revenue -- -- -- -- --
Total Revenue -4.50% -16.31% 11.60% -18.37% -29.13%
Cost of Revenue 8.18% -5.32% 2.23% -5.59% -319.62%
Gross Profit -7.74% -2.31% 39.45% -0.03% 526.83%
SG&A Expenses -18.11% -15.86% -20.44% -19.19% -13.35%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses 605.93% -83.18% 11.54% -203.03% 100.79%
Total Operating Expenses -11.93% -8.09% -15.85% -9.27% 0.98%
Operating Income 14.68% 4.44% 23.35% 6.64% -19.76%
Income Before Tax 18.81% 3.67% 26.47% 5.02% -5.11%
Income Tax Expenses -- -- -- -- -253.49%
Earnings from Continuing Operations 18.61% 3.67% 26.47% 5.02% -4.93%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 18.61% 3.67% 26.47% 5.02% -4.93%
EBIT 14.68% 4.44% 23.35% 6.64% -19.76%
EBITDA 15.26% 4.08% 24.30% 7.09% -21.07%
EPS Basic 29.60% 16.67% 36.74% 9.76% -3.25%
Normalized Basic EPS 25.39% 16.67% 36.74% 12.75% -11.27%
EPS Diluted 29.60% 16.79% 36.75% 9.76% -2.96%
Normalized Diluted EPS 25.39% 16.67% 36.74% 12.75% -11.27%
Average Basic Shares Outstanding 15.61% 15.60% 16.24% 5.25% 1.63%
Average Diluted Shares Outstanding 15.61% 15.60% 16.24% 5.25% 1.63%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings